Award
National Institute of General Medical Sciences 5R16GM153690-03
Targeting cell fusion as a novel strategy to tackle JQ1 resistance in triple negative breast cancer
Recipient
National Institute of General Medical Sciences (NIGMS), part of NIH
Award Amount
$137,333.00
Ceiling
$137,333.00
Awarded
April 02, 2026
Identifier
5R16GM153690-03
Research project funded by NIH/NIGMS to study cell fusion in triple negative breast cancer to overcome JQ1 drug resistance, running from 2024 to 2028 with an award of $137,333.
Description
This project involves research on breast cancer, specifically targeting cell fusion mechanisms to prevent drug resistance. It is funded by NIH/NIGMS and includes bioinformatics and molecular biology techniques. The project duration is from May 2024 to April 2028 with a total award amount of $137,333.